Commissariat A LEnergie Atomique Et Aux Energies Alternatives;Commissariat A L'Energie Atomique Et Aux Energies Alternatives
发明人:
Mouthon, Franck,Charveriat, Mathieu
申请号:
AU2017228472
公开号:
AU2017228472A1
申请日:
2017.09.11
申请国别(地区):
AU
年份:
2017
代理人:
摘要:
#$%^&*AU2017228472A120171005.pdf#####ABSTRACT This invention relates to improvements in therapeutic neurological and neuropsychic treatments using acetylcholinesterase inhibitors. More specifically, the invention enables the effects of a reversible acetylcholinesterase inhibitor to be potentiated by certain molecules, referred to here as 5 connexin-blocking agents. Said connexin-blocking agent is preferably meclofenamic acid.